EJNMMI Radiopharmacy and Chemistry View Homepage


Ontology type: schema:Periodical      Open Access: True


Journal Info

START YEAR

2016

PUBLISHER

Springer International Publishing

LANGUAGE

en

HOMEPAGE

http://ejnmmipharmchem.springeropen.com

Recent publications latest 20 shown

  • 2019-12 Synthesis of a benzoxazinthione derivative of tanaproget and pharmacological evaluation for PET imaging of PR expression
  • 2019-12 Radiosynthesis and in vivo evaluation of 11C-labeled BMS-193885 and its desmethyl analog as PET tracers for neuropeptide Y1 receptors
  • 2019-12 Radiochemical and analytical aspects of inter-institutional quality control measurements on radiopharmaceuticals
  • 2019-12 Automated synthesis of [11C]L-glutamine on Synthra HCN plus synthesis module
  • 2019-12 The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented?
  • 2019-12 Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers
  • 2018-12 Comparison of fully-automated radiosyntheses of [11C]erlotinib for preclinical and clinical use starting from in target produced [11C]CO2 or [11C]CH4
  • 2018-12 Synthesis of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand in an automated synthesis platform
  • 2018-12 Production of novel diagnostic radionuclides in small medical cyclotrons
  • 2018-12 Radiosynthesis and evaluation of an 18F–labeled silicon containing exendin-4 peptide as a PET probe for imaging insulinoma
  • 2018-12 An alternative methodology for the determination of the radiochemical purity of 11C-methionine
  • 2018-12 Synthesis, radiosynthesis, in vitro and first in vivo evaluation of a new matrix metalloproteinase inhibitor based on γ-fluorinated α-sulfonylaminohydroxamic acid
  • 2018-12 A random walk approach to estimate the confinement of α-particle emitters in nanoparticles for targeted radionuclide therapy
  • 2018-12 Publisher Correction to EJNMMI Radiopharmacy and Chemistry Volume 1 (2016)
  • 2018-12 Synthesis and preliminary preclinical evaluation of fluorine-18 labelled isatin-4-(4-methoxyphenyl)-3-thiosemicarbazone ([18F]4FIMPTC) as a novel PET tracer of P-glycoprotein expression
  • 2018-12 Preparation and preclinical evaluation of a 68Ga-labelled c(RGDfK) conjugate comprising the bifunctional chelator NODIA-Me
  • 2018-12 A new two-strip TLC method for the quality control of technetium-99m mercaptoacetyl-triglycine (99mTc-MAG3)
  • 2018-12 Futureproofing [18F]Fludeoxyglucose manufacture at an Academic Medical Center
  • 2018-12 A high molar activity 18F-labeled TAK-875 derivative for PET imaging of pancreatic β-cells
  • 2018-12 Metabolite profiling with HPLC-ICP-MS as a tool for in vivo characterization of imaging probes
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H29048", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Nuclear Medicine", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H29005", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Imaging / Radiology", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/C31000", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Nuclear Chemistry", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H69000", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Pharmacotherapy", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/B1700X", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Molecular Medicine", 
            "type": "DefinedTerm"
          }
        ], 
        "description": "

    EJNMMI Radiopharmacy and Chemistry is a peer-reviewed\u00a0open access Journal and publishes new research in the field of development of new imaging and radionuclide-based therapeutic agents for application in nuclear medicine and molecular imaging. The journal provides a platform for chemists, pharmacists and basic scientists to present their views and scientific work. In addition, the journal provides insight into novel concepts of imaging or radionuclide-based therapeutic agent applications of relevance for the whole molecular imaging community. The journal reports original research articles, review papers, guidelines on the application of imaging or radionuclide therapy agents, editorials, and letters to the editor. Research articles on novel radiochemistry, new radiopharmaceuticals including their first biological evaluation, molecular imaging agents including optical imaging, MRI, and hybrid probes, are the main focus of the journal. To translate imaging and radionuclide therapy agents to the clinic, legislative issues related to their production and safety can be presented as well in the form of guidelines or position papers.

    Peer review is conducted using Editorial Manager\u00ae, supported by a database of international experts. This database is shared with the journals European Journal of Nuclear Medicine and Molecular Imaging, EJNMMI Physics, EJNMMI Research, and the European Journal of Hybrid Imaging.

    ", "editor": [ { "familyName": "Elsinga", "givenName": "Philip H.", "type": "Person" } ], "id": "sg:journal.1157056", "inLanguage": [ "en" ], "isAccessibleForFree": true, "issn": [ "2365-421X" ], "license": "Fully Open Access", "name": "EJNMMI Radiopharmacy and Chemistry", "productId": [ { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "493509" ] }, { "name": "springer_id", "type": "PropertyValue", "value": [ "41181" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "2016247781" ] }, { "name": "dimensions_id", "type": "PropertyValue", "value": [ "157056" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "101714628" ] } ], "publisher": { "name": "Springer International Publishing", "type": "Organization" }, "publisherImprint": "Springer", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1157056" ], "sdDataset": "journals", "sdDatePublished": "2019-03-18T11:05", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "file:///home/ubuntu/piotr/scigraph_export/journals_20190313_sn_only.jsonl", "startYear": "2016", "type": "Periodical", "url": "http://ejnmmipharmchem.springeropen.com" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1157056'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1157056'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1157056'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1157056'


     

    This table displays all metadata directly associated to this object as RDF triples.

    67 TRIPLES      20 PREDICATES      29 URIs      20 LITERALS      8 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1157056 schema:about sg:ontologies/product-market-codes/B1700X
    2 sg:ontologies/product-market-codes/C31000
    3 sg:ontologies/product-market-codes/H29005
    4 sg:ontologies/product-market-codes/H29048
    5 sg:ontologies/product-market-codes/H69000
    6 schema:description <p><i>EJNMMI Radiopharmacy and Chemistry </i>is a peer-reviewed open access Journal and publishes new research in the field of development of new imaging and radionuclide-based therapeutic agents for application in nuclear medicine and molecular imaging. The journal provides a platform for chemists, pharmacists and basic scientists to present their views and scientific work. In addition, the journal provides insight into novel concepts of imaging or radionuclide-based therapeutic agent applications of relevance for the whole molecular imaging community. The journal reports original research articles, review papers, guidelines on the application of imaging or radionuclide therapy agents, editorials, and letters to the editor. Research articles on novel radiochemistry, new radiopharmaceuticals including their first biological evaluation, molecular imaging agents including optical imaging, MRI, and hybrid probes, are the main focus of the journal. To translate imaging and radionuclide therapy agents to the clinic, legislative issues related to their production and safety can be presented as well in the form of guidelines or position papers.</p><p>Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with the journals <i>European Journal of Nuclear Medicine and Molecular Imaging, EJNMMI Physics,</i> <i>EJNMMI Research, </i>and the<i> European Journal of Hybrid Imaging.</i></p>
    7 schema:editor Nad27b601dccf471fa3106453e03a7a07
    8 schema:inLanguage en
    9 schema:isAccessibleForFree true
    10 schema:issn 2365-421X
    11 schema:license Fully Open Access
    12 schema:name EJNMMI Radiopharmacy and Chemistry
    13 schema:productId N82e38b0fa2e24bc5b1edf7e1baac417c
    14 N8adc8a1286284d9f974aa553d7c9d825
    15 N9132c99a38444b2b8439cdfc72bcb051
    16 N96cb23acbee9404b9ef52a4029bea428
    17 Ncd48a31468974e678cc90b95be0cfbdb
    18 schema:publisher N1cc0f9ff2f014e1aa78f0832aaaf3bb2
    19 schema:publisherImprint Springer
    20 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1157056
    21 schema:sdDatePublished 2019-03-18T11:05
    22 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    23 schema:sdPublisher N12b2dbe9b80a42c39997e146d4b09221
    24 schema:startYear 2016
    25 schema:url http://ejnmmipharmchem.springeropen.com
    26 sgo:license sg:explorer/license/
    27 sgo:sdDataset journals
    28 rdf:type schema:Periodical
    29 N12b2dbe9b80a42c39997e146d4b09221 schema:name Springer Nature - SN SciGraph project
    30 rdf:type schema:Organization
    31 N1cc0f9ff2f014e1aa78f0832aaaf3bb2 schema:name Springer International Publishing
    32 rdf:type schema:Organization
    33 N82e38b0fa2e24bc5b1edf7e1baac417c schema:name nlm_unique_id
    34 schema:value 101714628
    35 rdf:type schema:PropertyValue
    36 N8adc8a1286284d9f974aa553d7c9d825 schema:name springer_id
    37 schema:value 41181
    38 rdf:type schema:PropertyValue
    39 N9132c99a38444b2b8439cdfc72bcb051 schema:name nsd_ids_id
    40 schema:value 493509
    41 rdf:type schema:PropertyValue
    42 N96cb23acbee9404b9ef52a4029bea428 schema:name lccn_id
    43 schema:value 2016247781
    44 rdf:type schema:PropertyValue
    45 Nad27b601dccf471fa3106453e03a7a07 rdf:first Nc8c2ac255ba84a45867f5bc5366971b2
    46 rdf:rest rdf:nil
    47 Nc8c2ac255ba84a45867f5bc5366971b2 schema:familyName Elsinga
    48 schema:givenName Philip H.
    49 rdf:type schema:Person
    50 Ncd48a31468974e678cc90b95be0cfbdb schema:name dimensions_id
    51 schema:value 157056
    52 rdf:type schema:PropertyValue
    53 sg:ontologies/product-market-codes/B1700X schema:inDefinedTermSet sg:ontologies/product-market-codes/
    54 schema:name Molecular Medicine
    55 rdf:type schema:DefinedTerm
    56 sg:ontologies/product-market-codes/C31000 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    57 schema:name Nuclear Chemistry
    58 rdf:type schema:DefinedTerm
    59 sg:ontologies/product-market-codes/H29005 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    60 schema:name Imaging / Radiology
    61 rdf:type schema:DefinedTerm
    62 sg:ontologies/product-market-codes/H29048 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    63 schema:name Nuclear Medicine
    64 rdf:type schema:DefinedTerm
    65 sg:ontologies/product-market-codes/H69000 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    66 schema:name Pharmacotherapy
    67 rdf:type schema:DefinedTerm
     




    Preview window. Press ESC to close (or click here)


    ...